Nolato Strengthens Its Operations with Major Investments

On 13 October, Nolato Magyarország Kft., a Mosonmagyaróvár-based manufacturer of medical technology and healthcare products, inaugurated the largest investment in its history. The development will increase the company’s manufacturing and warehousing space by more than 50% and upgrade its equipment.

At the same time, the company’s management announced an even larger investment: an 8,000-square-metre, multi-storey production facility where drug self-administration systems will be manufactured for one of the world’s largest and most innovative pharmaceutical companies. These developments are the largest investments ever undertaken by the Swedish Nolato Group, which places a strong emphasis on innovation in Hungary.

Following the recently inaugurated HUF 7 billion development—of which HUF 1.4 billion was provided as state aid—the company will invest a further HUF 28 billion in its expansion, supported by an additional HUF 4 billion in state aid.

Further details: kormany.hu

We are proud that MAPI, acting as an adviser, was able to contribute to Nolato’s latest investments in Hungary.